Cochrane review says amyloid-targeting Alzheimer's drugs are ineffective, but the Alzheimer's Association and drug makers ...

A newly published study shows that while disease-modifying therapies (DMTs) may offer substantially greater health benefits ...

Please provide your email address to receive an email when new articles are posted on . Cell transformation begins with slow degeneration and progresses rapidly. The data confirmed results from ...

Alzheimer's patients who take Leqembi retain the benefits of the treatment even when they stop taking it, new research by Eisai shows. The analysis found Alzheimer's disease continued to progress ...

Omics analysis is the process of analyzing large data sets to extract meaningful information about biological molecules—genes, DNA, RNA, proteins, metabolites or more—with the goal of illuminating ...

GSK and Alector have stopped a phase 2 trial of their Alzheimer’s disease drug candidate after an interim analysis found the study was unlikely to hit its primary endpoint. The study randomized 367 ...

New research examines the effects of newer drugs for Alzheimer’s disease.

The researchers, working under the banner of the International Genomics of Alzheimer’s Project (I-GAP), used a method of discovery known as case–control genome-wide association studies (GWASs). In ...

While Alzheimer’s disease has no cure, you can manage symptoms like memory loss and cognitive decline through medications, experimental approaches, and off-label drug uses. Non-drug treatments like ...

New AI-powered app analyses speech patterns to detect Alzheimer’s disease in its earliest stages, improving early diagnosis ...

Here’s what a new study found about the link between blood glucose levels and dementia. A recent data analysis found a link between blood sugar spikes after meals and a higher risk of Alzheimer’s ...